The Foundation has just pledged to invest $ 22 million to the CHU Sainte-Justine, making it the largest donor in the history of the hospital.
This money will finance projects in the new Unité de recherche en immuno-hémato-oncologie Charles-Bruneau.
For the thousands of children with cancer in Quebec, hope lies in research. That is why the Fondation Charles-Bruneau is committed to the CHU Sainte-Justine in order to achieve a first complete sequencing approach of the DNA of the human genome, in order to better determine the characteristics of each tumor, to specify the diagnosis, to identify anomalies in question and deal with targeted therapies. This approach paves the way for the discovery of biological markers of efficacy, genetic markers that, once detected, will give a clue as to the most effective treatment to be prescribed and the probable evolution of the disease, with a goal of improvement of the quality of life after recovery without side-effects or complications.
Two objectives will serve to guide researchers: finding a cure for the 20% of children whose cancer is resistant to treatment, and improving the quality of life of children in remission so that they can enjoy a true recovery.